Trials / Conditions / Neoplastic Syndrome

Neoplastic Syndrome

10 registered clinical trials studyying Neoplastic Syndrome.

Status	Trial	Sponsor	Phase
Completed	Studying Gene Expression in Samples From Younger Patients With Neuroblastoma NCT01553448	Children's Oncology Group	—
Completed	AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors NCT00427349	Eastern Cooperative Oncology Group	Phase 2
Unknown	Disease-Specific Questionnaire in Assessing Quality of Life in Patients With Gastrointestinal-Related Neuroend NCT00454376	National Cancer Institute (NCI)	—
Terminated	Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors NCT00227617	University of California, San Francisco	Phase 2 / Phase 3
Completed	Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Face NCT00489086	UCSF Benioff Children's Hospital Oakland	Phase 2
Completed	Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroe NCT00416767	Federation Francophone de Cancerologie Digestive	Phase 2
Completed	Thalidomide in Treating Patients With Metastatic Neuroendocrine Tumors NCT00027638	Memorial Sloan Kettering Cancer Center	Phase 2
Completed	Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer NCT00006368	Novartis Pharmaceuticals	Phase 1
Terminated	Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer NCT00002947	Yale University	Phase 1
Completed	Topical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy Participants NCT00433485	Yale University	Phase 1